Skip to main content
BCAT
NYSE Finance

BCAT Rights Offering: 5 Rights Buy 1 Share at Up to 1.5% Discount to NAV

Tom Rudovsky · Reported by BusinessWire
Sentiment info
Neutral
Importance info
7
Price
$15.75
Mkt Cap
$1.686B
52W Low
$13.73
52W High
$16.2
52W Position info
15% above low
Off High info
2.8% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BCAT is trading near its 52-week low of $13.73 (15% above the low).

Summary

BlackRock Capital Allocation Term Trust (BCAT) announced the full terms of its transferable rights offering. Record date shareholders as of September 25, 2026 will receive one right per share, with five rights required to purchase one new share. The subscription price will be set at 95% of the average of the last reported sales price on the expiration date and the four preceding trading days, subject to a maximum of $0.01 below NAV and a minimum of 98.5% of NAV. The offering expires October 21, 2026, and rights are expected to trade on the NYSE under the symbol 'BCAT RT' until October 20, 2026. The fund is maintaining its current distribution level through the remainder of 2026, and the adviser will bear all offering expenses. The offering is dilutive to existing shareholders who do not participate, but the discount to NAV is modest and the fund is trading near its 52-week high, suggesting investor demand may be strong.

At the time of this announcement, BCAT was trading at $15.75 on NYSE in the Finance sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $13.73 to $16.20. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BCAT - Latest Insights

BCAT
Sep 10, 2026, 5:25 PM EDT
Filing Type: 497AD
Importance Score:
7
Price at Filing: $15.98
Real-time Price: $15.13 info
Change: -$0.8498 (-5%) info
Market Cap: $1.686B info